Analyst Ratings for Immunovant (IMVT)
IMVT Rating Summary
IMVT Price Target Summary
- Highest: $57.00 (Citi)
- Lowest: $18.00 (Goldman Sachs)
- Average: $41.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.25 (+54.7%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$41.25 (+54.7%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
50.00 (N/A) |
397.83 (26.66) |
-93.3% | Details |
| 10/14/2025 | Truist Securities » Updated 2/9/2026 |
Danielle Brill | New Coverage | Hold (N/A) |
23.00 (22.00) |
17.35 (26.66) |
53.66% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
